Breaking News
Sort by:
Top Post
Mologic and Alamar Biosciences Collaborate to Develop a next Generation COVID-19 Antigen Test
Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable […]
BioWin Spearheads Talent Now, a Unique Initiative to Tackle Recruitment Shortages and Challenges in the Healthtech Industry
BioWin, the health cluster of Wallonia, today announces the launch of `Talent Now’, a new […]
Medtronic and GE Healthcare Announce a Collaboration to Meet Growing Need for Outpatient Care
Providing excellent care inside and outside of the traditional hospital is the new normal for […]
Bonus BioGroup's COVID Drug - MesenCure - Can Help a Life-threatening Complication Seen in Cancer Patients
Bonus BioGroup (TASE: BONS), a clinical-stage Israeli biotechnology company engaged in the research and development […]
IMPLICITY Raises $23M to Broaden Use of Its Cardiac Remote Monitoring Platform
IMPLICITY ®,a, leader in remote patient monitoring and cardiac data management solutions, today announced it […]
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity
RVAC Medicines Pte. Ltd. (“RVAC”), an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC […]
Mobile Cataract Units and Same-day Hip Replacements Helping Thousands Get NHS Treatment
Same-day hip replacements, one stop shops and mobile cataract units are just some of the […]
Syndrome Post-COVID: First Results of the Collaboration Between Fondamental & GeNeuro
GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune […]
Amniotics Receives Approval for Phase I/II Study of Pulmostem™ in Hospitalized COVID-19 Patients
Amniotics AB (publ) (Nasdaq Stockholm: AMNI) today announced that it has received approval by regulatory […]
Major New Review of Health Inequalities Lays Roadmap For The Role of Business in Levelling Up
A major review of health inequities published today, 4th April, lays a roadmap for the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more